Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway
文献类型：期刊论文
| 作者 | Ding, LL; Li, JM; Song, BL; Xiao, X; Huang, WD; Zhang, BF; Tang, XW; Qi, M; Yang, QM; Yang, QL |
| 刊名 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
 |
| 出版日期 | 2014 |
| 卷号 | 351期号:2页码:474-483 |
| 通讯作者 | Yang, L (reprint author), Shanghai Univ Tradit Chinese Med, Inst Tradit Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Cai Lun Rd 1200, Shanghai 201203, Peoples R China.,yangli7951@hotmail.com ; wangzht@hotmail.com |
| 英文摘要 | Sterol regulatory element-binding proteins (SREBPs) are major transcription factors regulating the expression of genes involved in biosynthesis of cholesterol, fatty acids, and triglycerides. We investigated the effect of the specific SREBP suppressor andrographolide, a natural compound isolated from Andrographis paniculata, on the regulation of SREBP signaling by use of Western blot, reporter gene assay, and quantitative real-time polymerase chain reaction analysis. In addition, the antiobesity effects of andrographolide were evaluated in C57BL/6 mice with high-fat diet (HFD)-induced obesity. Our results showed that andrographolide downregulated the expressions of SREBPs target genes and decreased cellular lipid accumulation in vitro. Further, andrographolide (100 mg/kg per day) attenuated HFD-induced body weight gain and fat accumulation in liver or adipose tissues, and improved serum lipid levels and insulin or glucose sensitivity in HFD-induced obese mice. Andrographolide effectively suppressed the respiratory quotient, energy expenditure, and oxygen consumption, which may have contributed to the decreased body-weight gain of the obese mice fed with a HFD. Consistently, andrographolide regulated SREBP target genes and metabolism-associated genes in liver or brown adipose tissue, which may have directly contributed to the lower lipid levels and enhanced insulin sensitivity. Taken together, our results indicated that andrographolide ameliorated lipid metabolism and improved glucose use in mice with HFD-induced obesity. Andrographolide has potential as a leading compound in the prevention or treatment of obesity and insulin resistance. |
| 学科主题 | Pharmacology & Pharmacy |
| 类目[WOS] | Pharmacology & Pharmacy |
| 关键词[WOS] | RECEPTOR LXR-ALPHA ; METABOLIC SYNDROME ; X-RECEPTOR ; ADIPOCYTE DIFFERENTIATION ; STATIN INTOLERANCE ; ACID-METABOLISM ; GENE-EXPRESSION ; LDL RECEPTOR ; CHOLESTEROL ; LIVER |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000348739800017 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/137]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Ding, LL,Li, JM,Song, BL,et al. Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2014,351(2):474-483. |
| APA | Ding, LL.,Li, JM.,Song, BL.,Xiao, X.,Huang, WD.,...&Wang, ZT.(2014).Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,351(2),474-483. |
| MLA | Ding, LL,et al."Andrographolide Prevents High-Fat Diet-Induced Obesity in C57BL/6 Mice by Suppressing the Sterol Regulatory Element-Binding Protein Pathway".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 351.2(2014):474-483. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。